Coronavirus (COVID-19): Latest Updates | Visitation PoliciesVisitation PoliciesVisitation PoliciesVisitation PoliciesVisitation Policies | How We're Keeping You Safe | Vaccine InformationVaccine InformationVaccine Information
At Wilmot, more than 100 researchers work together to transform laboratory discoveries and clinical challenges into solutions for the patients and communities we serve.
Wilmot’s scientists are organized into three multidisciplinary research programs that explore the biology of cancer, the cancer microenvironment, and the toxicities and side effects of cancer and its treatment.
Wilmot has a large, dedicated group of scientists from 30 academic departments across the University of Rochester who are devoted to studying cancer.
Shared Resources provide cost-effective access to state-of-the art technologies, expert guidance and training, and scientific consultation for Wilmot researchers.
Clinical trials are the backbone of cancer research, identifying better and safer treatments for patients.
Wilmot offers a variety of intramural funding mechanisms to support cancer researchers, as well as resources for extramural funding.
Wilmot members form a community of scientists committed to investigating the causes, diagnosis, treatment, and prevention of cancer and its side effects.